Prof. dr. Steven Hoekstra is an Associate Professor of Atomic and Molecular Physics at the University of Groningen's Faculty of Science and Engineering, within the Van Swinderen Institute. His research focuses on precision measurements using cold molecules to explore fundamental physics, including Stark deceleration, laser cooling, and searches for physics beyond the Standard Model. He leads the NL-eEDM program at Nikhef, investigating the electron's electric dipole moment. Hoekstra is also involved in educational innovation, having received the Teacher of the Year award (2020) and a Senior Teacher Qualification (2023). He has supervised over 11 PhD theses and currently mentors 5 students. His work combines experimental techniques with theoretical insights, addressing questions like symmetry violations and quantum dynamics. Key projects include manipulating BaF molecules with electrostatic fields and exploring levitated nanoparticles as sensors. Hoekstra has secured major grants, including NWO VICI (2022) and VIDI (2013), and collaborates internationally on projects like the European Strategy for particle physics. Recent articles highlight advancements in molecular beam control, spin-precession methods for EDM searches, and opportunities in radioactive molecules. He actively participates in the Physics Olympiad Netherlands as chair, contributing to science outreach and education.
Dr. Ting-Feng Lin is an Assistant Professor at the Cell Biology, Neurobiology and Biophysics department within the Faculty of Science at Utrecht University, Netherlands. His research focuses on understanding the mechanisms of learning and memory formation in the cerebellum, particularly how synaptic and intrinsic plasticity mechanisms coordinate to regulate neuronal signaling and behavior. He employs advanced microscopy, optogenetic, and chemogenetic techniques in transparent zebrafish models to study these processes in vivo, with implications for neurodevelopmental disorders like autism spectrum disorder (ASD) and schizophrenia. 2025: Assistant Professor, Utrecht University 2019-2025: Postdoctoral Researcher, University of Chicago 2015-2019: PhD in Neuroscience, Neuroscience Center Zurich (ZNZ) 2010-2014: MS in Physiology, National Taiwan University 2006-2010: BS in Sports Medicine, China Medical University His work investigates how sensory experiences shape cerebellar processing during development, focusing on climbing fiber pathways and their role in sensory prediction errors. His group also studies the interaction between synaptic, intrinsic, and structural plasticity mechanisms in neural circuits, using zebrafish models with genetic modifications (e.g., Grid2 knockout) to model human neurological conditions. Dr. Lin has received scientific recognition including the SfN Trainee Professional Development Award for his work on Purkinje cell plasticity and the JNS Meeting Award for research on parallel fiber ramping activity and LTD. His publications span topics from cerebellar plasticity to voltage-gated K+ channel dynamics, reflecting his interdisciplinary approach to neurobiology.
Pim de Vink is a doctoral researcher at Eindhoven University of Technology , affiliated with the Biomedical Engineering department and Chemical Biology group. Supervised by dr. L.-G. Milroy and prof. L. Brunsveld , his work bridges supramolecular chemistry and chemical biology , focusing on host/guest chemistry for protein complex modulation. Education: B.Sc. in Chemistry (2014) from University of Amsterdam M.Sc. in Biomedical Engineering (2016) from TU/e Internship at Max Planck Institute for Molecular Physiology (2016) on gold-catalyzed synthesis Research Themes: His research develops switchable cucurbituril-based systems for light-controlled enzyme activation and artificial signaling networks. Key areas include protein-protein interaction stabilization , thermodynamic modeling , and allosteric nuclear receptor modulation . Publication Trends: Across JACS , Chemical Science , and RSC Chemical Biology , his work from 2017–2023 emphasizes supramolecular tools for biochemical applications. Notable contributions include 100-fold affinity enhancement of 14-3-3 ligands and UV-responsive cucurbituril release mechanisms . Grants: Funded by Netherlands Organization for Scientific Research (NWO) through Gravity program 024.001.035 and VICI grant 016.150.366.
Roger J.E. Jaspers is an Associate Professor at Eindhoven University of Technology (TU/e) and a part-time Professor at Ghent University in Belgium, affiliated with the Applied Physics and Science Education school and specializing in the Science and Technology of Nuclear Fusion. His research focuses on spectroscopic diagnostics of ion processes in fusion plasmas, particularly energetic alpha particles in fusion-born reactions. Collaborations include international fusion experiments like W7-X (Germany), JET (UK), and KSTAR (South Korea). He leads the scientific R&D for the ITER CXRS instrumentation system and has authored over 90 peer-reviewed papers. His work spans topics such as: Relativistic electrons Plasma energy transport Magneto-hydrodynamics (MHD) Fusion reactor instrumentation He contributes to educational initiatives like the TU/e Fusion Master program, FUSENET, and the Erasmus Mundus Programme FUSION-DC.
Dr. Julia Kamenz is an Assistant Professor (Rosalind Franklin fellow) at the University of Groningen's Faculty of Science and Engineering, where she leads research in the Molecular Systems Biology group within the Groningen Biomolecular Sciences and Biotechnology Institute (GBB). Her work focuses on understanding the molecular mechanisms that regulate cell cycle progression and cell division. Dr. Kamenz received her undergraduate training in Biochemistry at the University of Tuebingen, completed her PhD at the Friedrich Miescher Laboratory of the Max Planck Society under Dr. Silke Hauf (defended February 2015 with highest honors), and conducted postdoctoral research at Stanford University with Prof. James E. Ferrell. Her PhD work was supported by a Boehringer Ingelheim Fonds fellowship, and her postdoc was funded by a German Research Foundation (DFG) Postdoctoral Fellowship. Her research expertise spans cell cycle regulation and dynamics, post-translational modifications, Xenopus laevis model systems, and live cell microscopy. Dr. Kamenz investigates how kinases and phosphatases intricately regulate cell proliferation and division, with particular interest in the molecular mechanisms that ensure faithful chromosome segregation during mitosis. Her recent work has revealed novel insights into mitotic checkpoint signaling, particularly in early embryonic development where these checkpoints appear to function differently than in somatic cells. Dr. Kamenz's publication record demonstrates a strong focus on the dynamics of cell cycle transitions, with recent papers appearing in high-impact journals including Nature, The Journal of Biological Chemistry, and The Journal of Cell Biology. Her research integrates experimental biochemistry, live-cell imaging, and computational modeling approaches to understand complex regulatory networks. ERC Starting Grant (November 2022) NWO Vidi Grant (July 2021) Mansour Postdoctoral Travel Award (2019) Dr. Kamenz has secured significant research funding including an ERC Starting Grant (€1.5 million) and an NWO XS grant (€50,000) for her project "What limits mitotic checkpoint signaling in the early embryo?" Her research contributes to understanding fundamental biological processes with implications for developmental biology and cancer research. She collaborates extensively within the University of Groningen and with international partners, particularly in the areas of cell cycle research and biophysical approaches to biological problems. Dr. Kamenz leads a research group focused on cell cycle regulation within the Molecular Systems Biology division of the Groningen Biomolecular Sciences and Biotechnology Institute. Her lab combines biochemical approaches using Xenopus egg extracts with live-cell imaging and computational modeling to dissect the molecular mechanisms controlling cell division.
Prof. Casper Hoogenraad is a full professor in Molecular Neuroscience at the Department of Cell Biology, Faculty of Science, Utrecht University. His research focuses on understanding how intracellular protein trafficking underlies neuronal development and function, with particular emphasis on the microtubule cytoskeleton, synaptic cargo trafficking, and synaptic plasticity. He leads an active research group within Utrecht University's Cell Biology department and collaborates extensively with other neuroscience research groups. Education: PhD, Erasmus University Rotterdam (1996-2001) Postdoc, Massachusetts Institute of Technology (2002-2005) Hoogenraad's research spans three main themes: cytoskeleton dynamics during neurodevelopment and synaptic plasticity, motor proteins and adaptors as regulators of synaptic transport, and psychiatric and neurologic disease disorders linked to intracellular transport. His work combines genetics, biochemistry, molecular, and cellular biology methods in in vitro (neuron cultures), ex vivo (brain slices), and in vivo (mice) systems, along with advanced microscopy techniques including immunofluorescent confocal microscopy, high-resolution live cell imaging, and photo-activated localization microscopy (PALM). Analysis of Hoogenraad's recent publications reveals a strong focus on microtubule organization, neuronal polarity, and the molecular mechanisms underlying synaptic function and dysfunction. His work frequently explores how disruptions in intracellular transport contribute to neurological disorders including Alzheimer's disease, schizophrenia, and autism spectrum disorders, with particular attention to the relationship between cytoskeletal organization and cargo transport in neuronal compartments. Scientific Awards and Memberships: ZonMW-VIDI (2004) European Young Investigators (EURYI) award (2005) NWO-ALW VICI (2011) ERC Consolidator grants (2013) FENS-Kavli Network of Excellence (2014) European Molecular Biology Organization (EMBO) (2015) Young Academy of Europe (YAE) (2015) IBRO Kemali Prize (2016) Hoogenraad leads a research group studying neuronal development and function, with a particular focus on how intracellular transport mechanisms contribute to both normal brain function and neurological disorders. His laboratory employs a multidisciplinary approach combining molecular, cellular, and systems neuroscience techniques to investigate the molecular basis of neuronal polarity, synaptic plasticity, and the pathogenesis of neurological disorders. He has secured significant research funding through prestigious grants including ERC Consolidator grants. The Hoogenraad lab operates within the Cell Biology department at Utrecht University, collaborating with other research groups focusing on cellular dynamics, biophysics, and neurobiology. The lab utilizes advanced microscopy techniques including immunofluorescent confocal microscopy, high-resolution live cell imaging (spinning disc microscopy and total internal reflection fluorescence microscopy), and quantitative analysis using advanced high-resolution microscopy (photo-activated localization microscopy). Current lab technicians include Phebe Wulf and Bart de Haan.
Francesca Grisoni serves as an Assistant Professor in the Department of Biomedical Engineering at Eindhoven University of Technology (TU/e), where she currently leads the Molecular Machine Learning team. She additionally holds appointments as an ICMS Core member and Associate Professor at EAISI (Eindhoven Artificial Intelligence Systems Institute), reflecting her cross-disciplinary role at the intersection of computational science and biomedical applications. Academic Background : Grisoni completed her Environmental Sciences degree and earned a Ph.D. in 2016 from the University of Milano-Bicocca, where her dissertation focused on interpretable machine learning for molecular property prediction. During doctoral studies, she conducted research at ETH Zurich's Department of Chemistry and Applied Biosciences and the U.S. EPA's National Center for Computational Toxicology. Ph.D., University of Milano-Bicocca, 2016 (Dissertation: Interpretable machine learning for molecular property prediction) Environmental Sciences, University of Milano-Bicocca Her research integrates artificial intelligence, chemistry, and biology to develop computational methods for drug discovery, emphasizing wet-lab experimental validation alongside algorithmic innovation. Key focus areas include overcoming activity cliffs in molecular machine learning, generative modeling for scaffold hopping, and AI-augmented decision-making in therapeutic development, with the ultimate goal of achieving 'better decisions faster' in drug discovery pipelines. Analysis of her recent 2025 publications reveals a concentrated trend toward chemical language models and generative deep learning frameworks, specifically addressing low-data drug discovery challenges through active learning and neural network architectures. These works bridge computer science with pharmacology, targeting bioactivity prediction, molecular representation, and enzyme design while maintaining strong ties to experimental validation. Scientific Awards : Lush Young Researcher Prize Early Career Award 2022 from the Dutch Royal Netherlands Academy of Arts and Sciences (KNAW) ERC Starting Grant (2022) Grants and Supervision : Dr. Grisoni secured the prestigious ERC Starting Grant in 2022 to advance her molecular machine learning research. Institutional records indicate she has supervised 7 students (as shown in TU/e's 'Supervised Work (7)' repository section), though specific names aren't provided in the source material. Her group maintains active industry collaborations, including past engagement with Bracco Pharmaceuticals. Laboratory and Team : The Molecular Machine Learning team operates under the ICMS and EAISI frameworks, merging computational AI development with experimental wet-lab validation. This collaborative unit focuses on fragment-based molecular design, chirality representation (evidenced by fragSMILES work), and high-throughput nanoparticle identification using machine learning, as highlighted in recent press coverage and datasets.
Professor Roland J. Pieters is a distinguished academic at Utrecht University's Faculty of Science, where he serves as a full Professor in the Department of Chemical Biology and Drug Discovery. With over two decades of experience at the institution, he has progressed from Assistant Professor (1998) to Associate Professor (2005) and ultimately to Full Professor (2010-present). His research group is internationally recognized for groundbreaking work at the intersection of carbohydrate chemistry, chemical biology, and drug discovery, with particular emphasis on developing novel therapeutic approaches against bacterial infections and pathogenic mechanisms. Full Professor, Utrecht University (2010-present) Associate Professor, Utrecht University (2005-2010) Assistant Professor, Utrecht University (1998-2005) NWO Talent Post-doctoral Fellow, ETH-Zürich (1995-1996) Postdoctoral Researcher, University of Groningen (1996-1998) Professor Pieters earned his M.Sc. in Organic Chemistry from the University of Groningen in 1990, where he worked with Professor Ben Feringa, and completed his Ph.D. at MIT in 1995 under the supervision of Professor Julius Rebek Jr. His doctoral research focused on molecular recognition and template effects in bisubstrate systems, establishing the foundation for his lifelong interest in molecular interactions. Professor Pieters' research primarily centers on glycodrugs and the strategic interference with protein-carbohydrate interactions using multivalent systems of varying architectures. His laboratory has made significant contributions to understanding how rigid spacers in multivalent ligands can dramatically enhance binding affinity to target proteins, with applications against viral and bacterial adhesion proteins, toxins, galectins, and glycosidases. A particular focus has been on developing inhibitors for Pseudomonas aeruginosa lectin LecA, cholera toxin, influenza virus hemagglutinin, and more recently, SARS-CoV-2 spike protein interactions with host cell receptors. His group also pioneered the use of glyco- and peptide-microarrays for high-throughput screening of carbohydrate-protein interactions and drug discovery, particularly in the area of O-GlcNAcylation research. The publication record of Professor Pieters demonstrates consistent innovation in the field of multivalent carbohydrate-based therapeutics. His recent work (2020-2024) shows a strategic expansion into viral pathogenesis (particularly influenza and SARS-CoV-2), immune modulation through glycan recognition, and novel approaches to vaccine development. A notable trend is the increasing sophistication of multivalent architectures, moving from simple divalent systems to tetra- and hexavalent ligands with precisely engineered spatial arrangements. His research bridges fundamental chemical principles with practical therapeutic applications, maintaining strong connections to pharmaceutical development while advancing basic science understanding of carbohydrate-mediated biological processes. Professor Pieters' scientific achievements have been recognized with prestigious awards including a Fellowship from the Royal Netherlands Academy of Arts and Sciences (KNAW) in 1999 and a VICI personal grant from the Netherlands Organisation for Scientific Research (NWO) in 2008. These competitive awards reflect the significance and innovation of his research program. He has also served on editorial advisory boards, notably as Section Editor-in-Chief for Chemical Biology in the journal Molecules (2018-2022), contributing to the scholarly community through peer review and academic leadership. Fellowship of Royal Netherlands Academy of Sciences (KNAW), 1999 VICI, personal grant, NWO, 2008 Section Editor-in-Chief Chemical Biology for Molecules (2018-2022) Throughout his career, Professor Pieters has coordinated significant research projects including the EU project POLYCARB and secured competitive funding that has sustained his innovative research program. His laboratory has fostered numerous collaborations across Europe and internationally, creating a vibrant research environment that has trained many scientists now working in academia and industry. His research on multivalent carbohydrate systems represents a sustained intellectual contribution to chemical biology with direct relevance to developing new anti-infective strategies and therapeutic approaches. Professor Pieters leads an active research group within Utrecht University's Department of Chemical Biology and Drug Discovery, situated in the David de Wied Building. His laboratory maintains strong connections with other research groups both within Utrecht University and internationally, particularly in the fields of glycobiology, infectious diseases, and drug discovery. The research environment he has cultivated emphasizes interdisciplinary approaches, combining synthetic chemistry, biophysical analysis, and biological testing to address fundamental questions in carbohydrate-mediated biological processes with therapeutic applications.
Dr. Ed E. Moret is an Associate Professor of Computational Medicinal Chemistry at Utrecht University, where he serves as Managing Director of the Utrecht Institute for Pharmaceutical Sciences. He is a member of the Departmental Executive Board and Chair of the Board of Examiners of the School of Pharmacy. His academic career spans over three decades with significant contributions to pharmaceutical sciences. Utrecht University, Utrecht Institute for Pharmaceutical Sciences School of Pharmacy, Department of Chemical Biology and Drug Discovery Managing Director since January 2010 Dr. Moret's educational background includes completing Gymnasium-b at Gymnasium Camphusianum in Gorinchem in 1979, followed by pharmacy studies at Utrecht University until 1988. He earned his PhD in 1993 with research on calculations and simulations of DNA-alkylating cytostatics under supervision of Prof. L.H.M. Janssen and Prof. J.P.A.E. Tollenaere. He also conducted postdoctoral research at the Scripps Research Institute with Prof. A.J. Olson. His primary research interests focus on molecular recognition, particularly in auto-immune diseases, with expertise spanning computational medicinal chemistry, computer-aided drug discovery, cheminformatics, and bioinformatics. Dr. Moret's work bridges the gap between theoretical calculations and experimental validation in drug design. His research portfolio demonstrates a consistent trajectory from fundamental molecular interactions to applied drug discovery, with particular emphasis on enzyme inhibitors, carbohydrate-protein interactions, and molecular recognition processes. Analysis of his publication record reveals a strong focus on structure-based drug design, with significant contributions to the development of inhibitors for enzymes like β-glucocerebrosidase, NNMT, and neuraminidase. His work spans multiple therapeutic areas including lysosomal storage disorders, cancer metabolism, and infectious diseases. The interdisciplinary nature of his research is evident in the integration of computational approaches with experimental validation across biochemistry, pharmacology, and medicinal chemistry. Teacher of the Year (awarded three times by Pharmacy students) Member of editorial boards for Medicines and Conceptuur journals Secretary of Board of FIGON (2016) Secretary of Raad voor de Farmaceutische Wetenschappen (2024) Member of Board of Stichting Farmaceutische Erfgoed (2024) Dr. Moret has been actively involved in educational innovation, developing and coordinating the master's programme Drug Innovation, the profile Drug Regulatory Sciences, and the Honours programme Pharmaceutical Sciences. He has taught courses for pharmacy, chemistry, UCU and medical sciences students, as well as PhD courses in bioinformatics and computer-aided drug discovery. His educational contributions include developing an inquiry-based elective course on drug discovery, for which he published educational research. He holds BKO and SKO teaching qualifications and participated in the Centre of Excellence in University Teaching program. As Managing Director of the Utrecht Institute for Pharmaceutical Sciences, Dr. Moret leads research initiatives across chemical biology, drug discovery, and pharmaceutical sciences. His leadership extends to multiple advisory and editorial roles within the pharmaceutical research community, reflecting his significant contributions to both academic and professional spheres of pharmaceutical sciences.
Luc Brunsveld is a Full Professor of Chemical Biology at Eindhoven University of Technology's Department of Biomedical Engineering, embedded in the Institute for Complex Molecular Systems (ICMS). His research focuses on chemical biology approaches to modulate protein-protein interactions, with applications in drug discovery and synthetic cell development. Brunsveld has held academic roles at TU/e since 2008, preceded by postdoctoral fellowships at the Max Planck Institute and industry experience at Organon. Education: Master's (1997) and PhD (2001, cum laude) from TU/e and University of Illinois. Grants: ERC Starting, Proof of Concept, Advanced Grants; NWO Vici Grant (2015). Research interests include molecular glues, supramolecular chemistry, and artificial cells. Recent work highlights light-activatable proteases and beta-cell protection via ChREBP modulation. Awards include the NVBMB Award (2010) and KNCV Gold Medal (2013). Co-founder of Ambagon Therapeutics. Labs/Teams: ICMS Core Group, Chemical Biology Group.
Judith Risse is a Postdoctoral Researcher in the Bioinformatics (BIF) department at Wageningen University & Research. Her work focuses on genomic and evolutionary studies, including phylogenomic analysis of plant development, insect adaptation, and microalgal biotechnology. She has contributed to projects involving genome sequencing, transcriptome analysis, and nanopore technologies. Education: Completed her PhD in Bioinformatics (2014) under Prof. Bisseling and Dr. Leunissen, focusing on text-mining for metabolic pathway reconstruction. Research Interests: Floral development in Asteraceae, evolutionary adaptation in insects (e.g., field crickets), and genomic mechanisms of stress tolerance in microalgae. Her work integrates computational biology with experimental genomics. Publications: Key contributions include studies on dandelion floral genetics (2023), great tit genome inversion analysis (2023), and microalgal thermotolerance (2022). She has also published on cricket genomics (2020) and viral photosynthesis interactions (2022). Projects: Led a PhD project on text-mining applications in metabolic pathway analysis. Currently involved in collaborative projects on plant and animal genomics. Labs/Teams: Active in the BIF group at Wageningen, collaborating with institutions like St Andrews University and the Netherlands Institute of Ecology.
Detmer Sipkema is an Associate Professor at Wageningen University & Research, affiliated with the VLAG WIMEK faculty and the Department of Molecular Ecology. His research focuses on microbial ecology, marine biology, and biotechnology, particularly in aquaculture systems and sponge symbionts. He leads projects on metabolic modeling of marine bacteria, ecological impacts of seaweed farming, and probiotics development for aquaculture. Key research interests include microbial diversity, anaerobic digestion in aquaculture waste, and applications of artificial intelligence in microbial studies. He has supervised multiple PhD candidates exploring topics like microbial symbiosis, gut microbiota dynamics, and sustainable aquaculture practices. His work integrates multi-omics approaches, environmental microbiology, and bioprospecting for novel bioactive compounds. Sipkema has published widely on sponge microbiomes, anaerobic processes, and aquaculture sustainability. His datasets include bacterial community analyses from sponges and microalgae, contributing to understanding symbiotic relationships and biotechnological applications.
Dorota Kawa is an Assistant Professor at the Faculty of Science, Utrecht University , specializing in Plant Stress Resilience and Experimental and Computational Plant Development . Her research focuses on plant-microbiome interactions, root development under stress, and bioinformatics approaches to enhance crop sustainability. Education : PhD in Plant Physiology and Cell Biology (2017, University of Amsterdam) MSc in Plant Biotechnology (2011, Warsaw University of Life Sciences) BSc in Biotechnology (2010, Warsaw University of Life Sciences) Research Interests span plant adaptation to abiotic stresses, microbiome-driven root cell modifications, and computational modeling of development. She investigates how microbial communities and genetic pathways regulate root metabolomes and cellular traits, particularly under salt and drought stress. Publication Trends show her work centers on Striga resistance in cereal crops, stress-induced root architecture changes , and microbiome-root interactions . She explores auxin-independent signaling and mRNA decay mechanisms to improve multi-stress resilience. Teaching includes courses on plant development and research design at Utrecht University. Her work contributes to Pathways to Sustainability and Future Food initiatives.
Prof. Sofía Calero is a Full Professor at the Eindhoven University of Technology (TU/e) and Vice Dean of the Department of Applied Physics & Eindhoven School of Education. She leads the Materials Simulation & Modelling group, focusing on computational methods for renewable energy and nanostructured materials. MSc (1995) and PhD (2000), University Complutense of Madrid Marie Curie Fellow (2001–2003), University of Amsterdam Ramón y Cajal Fellow (2004) and Full Professor (2017) at University Pablo de Olavide (Spain) Her research bridges computational physics-chemistry and industrial applications, developing force fields, algorithms, and simulation methods to reverse-engineer material properties. She specializes in adsorption , metal-organic frameworks , zeolites , and molecular simulation , contributing to SDGs like climate action and clean energy. Recent publications focus on halide perovskites , carbon dioxide capture , and nanostructured materials , with software tools like RASPA and iRASPA as key outputs. Articles span Nano Letters , Chem , and Journal of Physical Chemistry C . ERC Proof of Concept Grant (2018) Marie Curie Excellence Award (2005) Fellow of the Royal Society of Chemistry (2024) She has supervised 36 research works and taught courses like Advanced Materials Modelling and Mechanics . Her work involves collaborations with industries and institutions across Europe.
Prof. Freek J. Beekman is a Full Professor and head of the Biomedical Imaging section within the Department of Radiation Science & Technology at Delft University of Technology (TU Delft), Faculty of Applied Sciences. He is a leading figure in biomedical imaging, with extensive contributions to nuclear imaging technologies, including SPECT, PET, and CT. His research spans detector development, image reconstruction algorithms, hybrid photonic imaging, and the application of artificial intelligence in medical imaging. Research Interests: His work focuses on advancing imaging modalities through innovations in hardware (e.g., multi-pinhole collimators) and software (e.g., deep learning for attenuation correction). He has pioneered ultra-high-resolution imaging systems, particularly for preclinical and clinical SPECT, and has developed integrated platforms like U-SPECT-BioFluo. His recent research explores glymphatic delivery of nanoparticles, infection imaging, and AI-driven reconstruction techniques, reflecting a strong translational focus. Publication Trends: His most recent publications (2021–2023) emphasize deep learning in SPECT, multi-isotope imaging, high-resolution ex vivo systems, and applications in neuroimaging and oncology. The articles demonstrate a consistent focus on improving image quality, resolution, and clinical utility through physics-informed and AI-enhanced methods. Scientific Awards: NWO Physics Valorization Prize Innovation of the Year Award by the World Molecular Imaging Society (2015, 2018) Edward Hoffman Memorial Award (2017) Bruce Hasegawa Memorial Award (2021) FOM Valorization Award (2013) TU Delft Entrepreneurial Award (2010) Advising and Grants: While specific student names are not listed, his leadership in large collaborative projects and supervision of numerous publications suggests active mentoring. He has secured significant funding through national and international grants, evidenced by his invention of over 20 patent families and successful technology transfer. His founding and leadership of MILabs BV (sold to Rigaku) highlights his impact on commercialization and industry-academia collaboration. Labs and Teams: He leads the Biomedical Imaging research group at TU Delft, which develops cutting-edge imaging systems such as VECTor (SPECT-PET) and EXIRAD-HE. His teams have produced technologies used globally in academic and pharmaceutical research, contributing to tracer development and therapeutic innovation.
